Median effective dose of esketamine for intranasal premedication in children with congenital heart disease

BACKGROUND: Esketamine is commonly used as a premedication for its sedation effect. However, the proper dosage for intranasal use in children with congenital heart disease (CHD) has not been determined. This study aimed to estimate the median effective dose (ED(50)) of esketamine for intranasal prem...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiajia, Liu, Daoqing, Bai, Jie, Gu, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114298/
https://www.ncbi.nlm.nih.gov/pubmed/37076798
http://dx.doi.org/10.1186/s12871-023-02077-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114298/
https://www.ncbi.nlm.nih.gov/pubmed/37076798
http://dx.doi.org/10.1186/s12871-023-02077-1

Ejemplares similares